# Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis

> **NCT01115244** · PHASE4 · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 1 (actual)

## Conditions studied

- Dermatitis Herpetiformis

## Interventions

- **DRUG:** Dapsone gel, 5%

## Key facts

- **NCT ID:** NCT01115244
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-07
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** poor enrollment and lack of funding
- **Last updated:** 2017-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01115244

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01115244, "Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01115244. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*